Articles

Gardiner, C.; Harrison, P.; Belting, M.; Böing, A.; Campello, E.; Carter, B. S.; Collier, M. E.; Coumans, F.; Ettelaie, C.; Van Es, N.; et al. Extracellular vesicles, tissue factor, cancer and thrombosis - discussion themes of the ISEV 2014 Educational Day. J. Extracell. Vesicles 2015, 4 (1), 26901.

Gardiner C, Harrison P, Belting M, et al. Extracellular vesicles, tissue factor, cancer and thrombosis - discussion themes of the ISEV 2014 Educational Day. J Extracell Vesicles. 2015;4(1):26901.

C. Gardiner et al., “Extracellular vesicles, tissue factor, cancer and thrombosis - discussion themes of the ISEV 2014 Educational Day,” J. Extracell. Vesicles, vol. 4, no. 1, pp. 26901, Mar. 2015.

Gardiner C, Harrison P, Belting M, Böing A, Campello E, Carter BS, et al. Extracellular vesicles, tissue factor, cancer and thrombosis - discussion themes of the ISEV 2014 Educational Day. J Extracell Vesicles. 2015 Mar;4(1):26901.

Yuana, Y.; Böing, A. N.; Grootemaat, A. E.; van der Pol, E.; Hau, C. M.; Cizmar, P.; Buhr, E.; Sturk, A.; Nieuwland, R. Handling and storage of human body fluids for analysis of extracellular vesicles. J. Extracell. Vesicles 2015, 4, 29260.

Yuana Y, Böing AN, Grootemaat AE, et al. Handling and storage of human body fluids for analysis of extracellular vesicles. J Extracell Vesicles. 2015;4:29260.

Y. Yuana et al., “Handling and storage of human body fluids for analysis of extracellular vesicles,” J. Extracell. Vesicles, vol. 4, pp. 29260, Nov. 2015.

Yuana Y, Böing AN, Grootemaat AE, van der Pol E, Hau CM, Cizmar P, et al. Handling and storage of human body fluids for analysis of extracellular vesicles. J Extracell Vesicles. 2015 Nov;4:29260.

Yuana, Y.; Levels, J.; Grootemaat, A.; Sturk, A.; Nieuwland, R. Co-isolation of extracellular vesicles and high-density lipoproteins using density gradient ultracentrifugation. J. Extracell. Vesicles 2014, 3 (1), 23262.

Yuana Y, Levels J, Grootemaat A, Sturk A, Nieuwland R. Co-isolation of extracellular vesicles and high-density lipoproteins using density gradient ultracentrifugation. J Extracell Vesicles. 2014;3(1):23262.

Y. Yuana, J. Levels, A. Grootemaat, A. Sturk, and R. Nieuwland, “Co-isolation of extracellular vesicles and high-density lipoproteins using density gradient ultracentrifugation,” J. Extracell. Vesicles, vol. 3, no. 1, pp. 23262, Jul. 2014.

Yuana Y, Levels J, Grootemaat A, Sturk A, Nieuwland R. Co-isolation of extracellular vesicles and high-density lipoproteins using density gradient ultracentrifugation. J Extracell Vesicles. 2014 Jul;3(1):23262.

De Jong, J. S.; Nieuwland, R.; Meijers, J. C.; Korporaal, S. J.; Akkerman, J. W. N.; Wilde, A. A.; Dekker, L. R. Altered platelet contents in survivors of early ischemic ventricular fibrillation: Perliminary findings. Platelets 2014, 25 (1), 71-74.

De Jong JS, Nieuwland R, Meijers JC, et al. Altered platelet contents in survivors of early ischemic ventricular fibrillation: Perliminary findings. Platelets. 2014;25(1):71-74.

J. S. De Jong et al., “Altered platelet contents in survivors of early ischemic ventricular fibrillation: Perliminary findings,” Platelets, vol. 25, no. 1, pp. 71-74, Feb. 2014.

De Jong JS, Nieuwland R, Meijers JC, Korporaal SJ, Akkerman JWN, Wilde AA, et al. Altered platelet contents in survivors of early ischemic ventricular fibrillation: Perliminary findings. Platelets. 2014 Feb;25(1):71-74.

Tersteeg, C.; Heijnen, H. F.; Eckly, A.; Pasterkamp, G.; Urbanus, R. T.; Maas, C.; Hoefer, I. E.; Nieuwland, R.; Farndale, R. W.; Gachet, C.; et al. FLow-Induced PRotrusions (FLIPRs) a platelet-derived platform for the retrieval of microparticles by monocytes and neutrophils. Circ. Res. 2014, 114 (5), 780-791.

Tersteeg C, Heijnen HF, Eckly A, et al. FLow-Induced PRotrusions (FLIPRs) a platelet-derived platform for the retrieval of microparticles by monocytes and neutrophils. Circ Res. 2014;114(5):780-791.

C. Tersteeg et al., “FLow-Induced PRotrusions (FLIPRs) a platelet-derived platform for the retrieval of microparticles by monocytes and neutrophils,” Circ. Res., vol. 114, no. 5, pp. 780-791, Feb. 2014.

Tersteeg C, Heijnen HF, Eckly A, Pasterkamp G, Urbanus RT, Maas C, et al. FLow-Induced PRotrusions (FLIPRs) a platelet-derived platform for the retrieval of microparticles by monocytes and neutrophils. Circ Res. 2014 Feb;114(5):780-791.

Majoor, C. J.; van de Pol, M. A.; Kamphuisen, P. W.; Meijers, J. C.; Molenkamp, R.; Wolthers, K. C. v. d. P. T. N. R. J. S. S. P. B. E. L. R. v. d. S. K. Evaluation of coagulation activation after rhinovirus infection in patients with asthma and healthy control subjects: an observational study. Resp. Res. 2014, 15 (1), 14.

Majoor CJ, van de Pol MA, Kamphuisen PW, Meijers JC, Molenkamp R, Wolthers KCvdPTNRJSSPBELRvdSK. Evaluation of coagulation activation after rhinovirus infection in patients with asthma and healthy control subjects: an observational study. Resp Res. 2014;15(1):14.

C. J. Majoor, M. A. van de Pol, P. W. Kamphuisen, J. C. Meijers, R. Molenkamp, and K. C. v. d. P. T. N. R. J. S. S. P. B. E. L. R. v. d. S. K. Wolthers, “Evaluation of coagulation activation after rhinovirus infection in patients with asthma and healthy control subjects: an observational study,” Resp. Res., vol. 15, no. 1, pp. 14, Feb. 2014.

Majoor CJ, van de Pol MA, Kamphuisen PW, Meijers JC, Molenkamp R, Wolthers KCvdPTNRJSSPBELRvdSK. Evaluation of coagulation activation after rhinovirus infection in patients with asthma and healthy control subjects: an observational study. Resp Res. 2014 Feb;15(1):14.

Coumans, F. A. W.; van der Pol, E.; Böing, A. N.; Hajji, N.; Sturk, G.; van Leeuwen, T. G.; Nieuwland, R. Reproducible extracellular vesicle size and concentration determination with tunable resistive pulse sensing. J. Extracell. Vesicles 2014, 3, 25922.

Coumans FAW, van der Pol E, Böing AN, et al. Reproducible extracellular vesicle size and concentration determination with tunable resistive pulse sensing. J Extracell Vesicles. 2014;3:25922.

F. A. W. Coumans et al., “Reproducible extracellular vesicle size and concentration determination with tunable resistive pulse sensing,” J. Extracell. Vesicles, vol. 3, pp. 25922, Dec. 2014.

Coumans FAW, van der Pol E, Böing AN, Hajji N, Sturk G, van Leeuwen TG, et al. Reproducible extracellular vesicle size and concentration determination with tunable resistive pulse sensing. J Extracell Vesicles. 2014 Dec;3:25922.

van der Pol, E.; Coumans, F. A. W.; Sturk, A.; Nieuwland, R.; van Leeuwen, T. G. Refractive index determination of nanoparticles in suspension using nanoparticle tracking analysis. Nano Lett. 2014, 14 (11), 6195-6201.

van der Pol E, Coumans FAW, Sturk A, Nieuwland R, van Leeuwen TG. Refractive index determination of nanoparticles in suspension using nanoparticle tracking analysis. Nano Lett. 2014;14(11):6195-6201.

E. van der Pol, F. A. W. Coumans, A. Sturk, R. Nieuwland, and T. G. van Leeuwen, “Refractive index determination of nanoparticles in suspension using nanoparticle tracking analysis,” Nano Lett., vol. 14, no. 11, pp. 6195-6201, Sep. 2014.

van der Pol E, Coumans FAW, Sturk A, Nieuwland R, van Leeuwen TG. Refractive index determination of nanoparticles in suspension using nanoparticle tracking analysis. Nano Lett. 2014 Sep;14(11):6195-201.

Böing, A. N.; van der Pol, E.; Grootemaat, A. E.; Coumans, F. A. W.; Sturk, A.; Nieuwland, R. Single-step isolation of extracellular vesicles by size-exclusion chromatography. J. Extracell. Vesicles 2014, 3, 23430.

Böing AN, van der Pol E, Grootemaat AE, Coumans FAW, Sturk A, Nieuwland R. Single-step isolation of extracellular vesicles by size-exclusion chromatography. J Extracell Vesicles. 2014;3:23430.

A. N. Böing, E. van der Pol, A. E. Grootemaat, F. A. W. Coumans, A. Sturk, and R. Nieuwland, “Single-step isolation of extracellular vesicles by size-exclusion chromatography,” J. Extracell. Vesicles, vol. 3, pp. 23430, Sep. 2014.

Böing AN, van der Pol E, Grootemaat AE, Coumans FAW, Sturk A, Nieuwland R. Single-step isolation of extracellular vesicles by size-exclusion chromatography. J Extracell Vesicles. 2014 Sep;3:23430.

van der Pol, E.; Coumans, F. A. W.; Grootemaat, A. E.; Gardiner, C.; Sargent, I. L.; Harrison, P.; Sturk, A.; van Leeuwen, T. G.; Nieuwland, R. Particle size distribution of exosomes and microvesicles determined by transmission electron microscopy, flow cytometry, nanoparticle tracking analysis, and resistive pulse sensing. J. Thromb. Haemost. 2014, 12 (7), 1182-1192.

van der Pol E, Coumans FAW, Grootemaat AE, et al. Particle size distribution of exosomes and microvesicles determined by transmission electron microscopy, flow cytometry, nanoparticle tracking analysis, and resistive pulse sensing. J Thromb Haemost. 2014;12(7):1182-1192.

E. van der Pol et al., “Particle size distribution of exosomes and microvesicles determined by transmission electron microscopy, flow cytometry, nanoparticle tracking analysis, and resistive pulse sensing,” J. Thromb. Haemost., vol. 12, no. 7, pp. 1182-1192, May. 2014.

van der Pol E, Coumans FAW, Grootemaat AE, Gardiner C, Sargent IL, Harrison P, et al. Particle size distribution of exosomes and microvesicles determined by transmission electron microscopy, flow cytometry, nanoparticle tracking analysis, and resistive pulse sensing. J Thromb Haemost. 2014 May;12(7):1182-.

Varga, Z.; Yuana, Y.; Grootemaat, A. E.; van der Pol, E.; Gollwitzer, C.; Krumrey, M.; Nieuwland, R. Towards traceable size determination of extracellular vesicles. J. Extracell. Vesicles 2014, 3, 23298.

Varga Z, Yuana Y, Grootemaat AE, et al. Towards traceable size determination of extracellular vesicles. J Extracell Vesicles. 2014;3:23298.

Z. Varga et al., “Towards traceable size determination of extracellular vesicles,” J. Extracell. Vesicles, vol. 3, pp. 23298, Feb. 2014.

Varga Z, Yuana Y, Grootemaat AE, van der Pol E, Gollwitzer C, Krumrey M, et al. Towards traceable size determination of extracellular vesicles. J Extracell Vesicles. 2014 Feb;3:23298.

van Rijsingen, I. A. W.; Bakker, A.; Azim, D.; Hermans-van Ast, J. F.; van der Kooi, A. J.; van Tintelen, J. P.; van den Berg, M. P.; Christiaans, I.; Lekanne dit Deprez, R. H.; Wilde, A. A. M.; et al. Lamin A/C mutation is independently associated with an increased risk of arterial and venous thromboembolic complications. Int. J. Cardiol. 2013, 168 (1), 472-477.

van Rijsingen IAW, Bakker A, Azim D, et al. Lamin A/C mutation is independently associated with an increased risk of arterial and venous thromboembolic complications. Int J Cardiol. 2013;168(1):472-477.

I. A. W. van Rijsingen et al., “Lamin A/C mutation is independently associated with an increased risk of arterial and venous thromboembolic complications,” Int. J. Cardiol., vol. 168, no. 1, pp. 472-477, Sep. 2013.

van Rijsingen IAW, Bakker A, Azim D, Hermans-van Ast JF, van der Kooi AJ, van Tintelen JP, et al. Lamin A/C mutation is independently associated with an increased risk of arterial and venous thromboembolic complications. Int J Cardiol. 2013 Sep;168(1):472-477.

Stoppelaar, S.; van 't Veer, C. v. d. B. F.; Nieuwland, R.; Hoogendijk, A.; de Boer, O.; Roelofs, J.; van der Poll, T. Protease activated receptor 4 limits bacterial growth and lung pathology during late stage Streptococcus pneumoniae induced pneumonia in mice. Thromb. Haemostasis 2013, 110 (3), 582-592.

Stoppelaar S, van 't Veer CvdBF, Nieuwland R, et al. Protease activated receptor 4 limits bacterial growth and lung pathology during late stage Streptococcus pneumoniae induced pneumonia in mice. Thromb Haemostasis. 2013;110(3):582-592.

S. Stoppelaar et al., “Protease activated receptor 4 limits bacterial growth and lung pathology during late stage Streptococcus pneumoniae induced pneumonia in mice,” Thromb. Haemostasis, vol. 110, no. 3, pp. 582-592, Sep. 2013.

Stoppelaar S, van 't Veer CvdBF, Nieuwland R, Hoogendijk A, de Boer O, Roelofs J, et al. Protease activated receptor 4 limits bacterial growth and lung pathology during late stage Streptococcus pneumoniae induced pneumonia in mice. Thromb Haemostasis. 2013 Sep;110(3):582-592.

Böing, A. N.; Stap, J.; Hau, C. M.; Afink, G. B.; Ris-Stalpers, C.; Reits, E. A.; Sturk, A.; Van Noorden, C. J. F.; Nieuwland, R. Active caspase-3 is removed from cells by release of caspase-3-enriched vesicles. Bba-mol. Cell Res. 2013, 1833 (8), 1844-1852.

Böing AN, Stap J, Hau CM, et al. Active caspase-3 is removed from cells by release of caspase-3-enriched vesicles. Bba-mol Cell Res. 2013;1833(8):1844-1852.

A. N. Böing et al., “Active caspase-3 is removed from cells by release of caspase-3-enriched vesicles,” Bba-mol. Cell Res., vol. 1833, no. 8, pp. 1844-1852, Aug. 2013.

Böing AN, Stap J, Hau CM, Afink GB, Ris-Stalpers C, Reits EA, et al. Active caspase-3 is removed from cells by release of caspase-3-enriched vesicles. Bba-mol Cell Res. 2013 Aug;1833(8):1844-1852.

Zakhrabova-Zwiauer, O. M.; Verkerk, A. O.; de Jong, J. S.; Sturk, A.; Nieuwland, R.; Tan, H. L. Acetylsalicylic acid prevents platelet-induced proarrhythmic effects on intracellular Ca2+ homeostasis in ventricular myocytes. Int. J. Cardiol. 2013, 167 (1), 303-305.

Zakhrabova-Zwiauer OM, Verkerk AO, de Jong JS, Sturk A, Nieuwland R, Tan HL. Acetylsalicylic acid prevents platelet-induced proarrhythmic effects on intracellular Ca2+ homeostasis in ventricular myocytes. Int J Cardiol. 2013;167(1):303-305.

O. M. Zakhrabova-Zwiauer, A. O. Verkerk, J. S. de Jong, A. Sturk, R. Nieuwland, and H. L. Tan, “Acetylsalicylic acid prevents platelet-induced proarrhythmic effects on intracellular Ca2+ homeostasis in ventricular myocytes,” Int. J. Cardiol., vol. 167, no. 1, pp. 303-305, Jul. 2013.

Zakhrabova-Zwiauer OM, Verkerk AO, de Jong JS, Sturk A, Nieuwland R, Tan HL. Acetylsalicylic acid prevents platelet-induced proarrhythmic effects on intracellular Ca2+ homeostasis in ventricular myocytes. Int J Cardiol. 2013 Jul;167(1):303-305.

Franz, C.; Böing, A. N.; Hau, C. M.; Montag, M.; Strowitzki, T.; Nieuwland, R.; Toth, B. Procoagulant tissue factor-exposing vesicles in human seminal fluid. J. Reprod. Immunol. 2013, 98 (1-2), 45-51.

Franz C, Böing AN, Hau CM, et al. Procoagulant tissue factor-exposing vesicles in human seminal fluid. J Reprod Immunol. 2013;98(1-2):45-51.

C. Franz et al., “Procoagulant tissue factor-exposing vesicles in human seminal fluid,” J. Reprod. Immunol., vol. 98, no. 1-2, pp. 45-51, Jun. 2013.

Franz C, Böing AN, Hau CM, Montag M, Strowitzki T, Nieuwland R, et al. Procoagulant tissue factor-exposing vesicles in human seminal fluid. J Reprod Immunol. 2013 Jun;98(1-2):45-51.

Yuana, Y.; Sturk, A.; Nieuwland, R. Extracellular vesicles in physiological and pathological conditions. Blood Rev. 2013, 27 (1), 31-39.

Yuana Y, Sturk A, Nieuwland R. Extracellular vesicles in physiological and pathological conditions. Blood Rev. 2013;27(1):31-39.

Y. Yuana, A. Sturk, and R. Nieuwland, “Extracellular vesicles in physiological and pathological conditions,” Blood Rev., vol. 27, no. 1, pp. 31-39, Jan. 2013.

Yuana Y, Sturk A, Nieuwland R. Extracellular vesicles in physiological and pathological conditions. Blood Rev. 2013 Jan;27(1):31-39.

Smit, K. F.; Oei, G. T.; Brevoord, D.; Stroes, E. S.; Nieuwland, R.; Schlack, W. S.; Hollmann, M. W.; Weber, N. C.; Preckel, B. Helium induces preconditioning in human endothelium in vivo. Anesthesiology 2013, 118 (1), 95-104.

Smit KF, Oei GT, Brevoord D, et al. Helium induces preconditioning in human endothelium in vivo. Anesthesiology. 2013;118(1):95-104.

K. F. Smit et al., “Helium induces preconditioning in human endothelium in vivo,” Anesthesiology, vol. 118, no. 1, pp. 95-104, Jan} doi={10.1097/ALN.0b013e3182751300. 2013.

Smit KF, Oei GT, Brevoord D, Stroes ES, Nieuwland R, Schlack WS, et al. Helium induces preconditioning in human endothelium in vivo. Anesthesiology. 2013 Jan} doi={10.1097/ALN.0b013e3182751300;118(1):95-104.

Nguyen, V. D.; Faber, D. J.; van der Pol, E.; van Leeuwen, T. G.; Kalkman, J. Dependent and multiple scattering in transmission and backscattering optical coherence tomography. Opt. Express 2013, 21 (24), 29145-29156.

Nguyen VD, Faber DJ, van der Pol E, van Leeuwen TG, Kalkman J. Dependent and multiple scattering in transmission and backscattering optical coherence tomography. Opt Express. 2013;21(24):29145-29156.

V. D. Nguyen, D. J. Faber, E. van der Pol, T. G. van Leeuwen, and J. Kalkman, “Dependent and multiple scattering in transmission and backscattering optical coherence tomography,” Opt. Express, vol. 21, no. 24, pp. 29145-29156, Nov. 2013.

Nguyen VD, Faber DJ, van der Pol E, van Leeuwen TG, Kalkman J. Dependent and multiple scattering in transmission and backscattering optical coherence tomography. Opt Express. 2013 Nov;21(24):29145-56.

van der Pol, E.; Coumans, F.; Varga, Z.; Krumrey, M.; Nieuwland, R. Innovation in detection of microparticles and exosomes. J. Thromb. Haemost. 2013, 11 (Suppl. 1), 36-45.

van der Pol E, Coumans F, Varga Z, Krumrey M, Nieuwland R. Innovation in detection of microparticles and exosomes. J Thromb Haemost. 2013;11(Suppl. 1):36-45.

E. van der Pol, F. Coumans, Z. Varga, M. Krumrey, and R. Nieuwland, “Innovation in detection of microparticles and exosomes,” J. Thromb. Haemost., vol. 11, no. Suppl. 1, pp. 36-45, Jun. 2013.

van der Pol E, Coumans F, Varga Z, Krumrey M, Nieuwland R. Innovation in detection of microparticles and exosomes. J Thromb Haemost. 2013 Jun;11(Suppl. 1):36-5.

Kalra, H.; Simpson, R. J.; Ji, H.; Aikawa, E.; Altevogt, P.; Askenase, P.; Bond, V. C.; Borràs, F. E.; Breakefield, X.; Budnik, V.; et al. Vesiclepedia: A Compendium for Extracellular Vesicles with Continuous Community Annotation. Plos Biol. 2012, 10 (12), 1-5.

Kalra H, Simpson RJ, Ji H, et al. Vesiclepedia: A Compendium for Extracellular Vesicles with Continuous Community Annotation. Plos Biol. 2012;10(12):1-5.

H. Kalra et al., “Vesiclepedia: A Compendium for Extracellular Vesicles with Continuous Community Annotation,” Plos Biol., vol. 10, no. 12, pp. 1-5, Dec. 2012.

Kalra H, Simpson RJ, Ji H, Aikawa E, Altevogt P, Askenase P, et al. Vesiclepedia: A Compendium for Extracellular Vesicles with Continuous Community Annotation. Plos Biol. 2012 Dec;10(12):1-5.

Kleinjan, A.; Böing, A. N.; Sturk, A.; Nieuwland, R. Microparticles in vascular disorders: how tissue factor-exposing vesicles contribute to pathology and physiology. Thromb. Res. 2012, 130 (Suppl 1), S71-S73.

Kleinjan A, Böing AN, Sturk A, Nieuwland R. Microparticles in vascular disorders: how tissue factor-exposing vesicles contribute to pathology and physiology. Thromb Res. 2012;130(Suppl 1):S71-S73.

A. Kleinjan, A. N. Böing, A. Sturk, and R. Nieuwland, “Microparticles in vascular disorders: how tissue factor-exposing vesicles contribute to pathology and physiology,” Thromb. Res., vol. 130, no. Suppl 1, pp. S71-S73, Oct. 2012.

Kleinjan A, Böing AN, Sturk A, Nieuwland R. Microparticles in vascular disorders: how tissue factor-exposing vesicles contribute to pathology and physiology. Thromb Res. 2012 Oct;130(Suppl 1):S71-S73.

van Doormaal, F. F.; Kleinjan, A.; Berckmans, R. J.; Mackman, N.; Manly, D.; Kamphuisen, P. W.; Richel, D. J.; Büller, H. R.; Sturk, A.; Nieuwland, R. Coagulation activation and microparticle-associated coagulant activity in cancer patients. Thromb. Haemostasis 2012, 108 (07), 160-165.

van Doormaal FF, Kleinjan A, Berckmans RJ, et al. Coagulation activation and microparticle-associated coagulant activity in cancer patients. Thromb Haemostasis. 2012;108(07):160-165.

F. F. van Doormaal et al., “Coagulation activation and microparticle-associated coagulant activity in cancer patients,” Thromb. Haemostasis, vol. 108, no. 07, pp. 160-165, Jul. 2012.

van Doormaal FF, Kleinjan A, Berckmans RJ, Mackman N, Manly D, Kamphuisen PW, et al. Coagulation activation and microparticle-associated coagulant activity in cancer patients. Thromb Haemostasis. 2012 Jul;108(07):160-165.

Tushuizen, M. E.; Diamant, M.; Peypers, E. G.; Hoek, F. J.; Heine, R. J.; Sturk, A.; Nieuwland, R. Postprandial changes in the phospholipid composition of circulating microparticles are not associated with coagulation activation. Thromb. Res. 2012, 130 (1), 115-121.

Tushuizen ME, Diamant M, Peypers EG, et al. Postprandial changes in the phospholipid composition of circulating microparticles are not associated with coagulation activation. Thromb Res. 2012;130(1):115-121.

M. E. Tushuizen et al., “Postprandial changes in the phospholipid composition of circulating microparticles are not associated with coagulation activation,” Thromb. Res., vol. 130, no. 1, pp. 115-121, Jul. 2012.

Tushuizen ME, Diamant M, Peypers EG, Hoek FJ, Heine RJ, Sturk A, et al. Postprandial changes in the phospholipid composition of circulating microparticles are not associated with coagulation activation. Thromb Res. 2012 Jul;130(1):115-121.

Rank, A.; Nieuwland, R.; Roesner, S.; Nikolajek, K.; Hiller, E.; Toth, B. Climacteric Lowers Plasma Levels of Platelet-Derived Microparticles: A Pilot Study in Pre- versus Postmenopausal Women. Acta Haematol-basel. 2012, 128 (1), 53-59.

Rank A, Nieuwland R, Roesner S, Nikolajek K, Hiller E, Toth B. Climacteric Lowers Plasma Levels of Platelet-Derived Microparticles: A Pilot Study in Pre- versus Postmenopausal Women. Acta Haematol-basel. 2012;128(1):53-59.

A. Rank, R. Nieuwland, S. Roesner, K. Nikolajek, E. Hiller, and B. Toth, “Climacteric Lowers Plasma Levels of Platelet-Derived Microparticles: A Pilot Study in Pre- versus Postmenopausal Women,” Acta Haematol-basel., vol. 128, no. 1, pp. 53-59, Jun. 2012.

Rank A, Nieuwland R, Roesner S, Nikolajek K, Hiller E, Toth B. Climacteric Lowers Plasma Levels of Platelet-Derived Microparticles: A Pilot Study in Pre- versus Postmenopausal Women. Acta Haematol-basel. 2012 Jun;128(1):53-59.

Rank, A.; Liebhardt, S.; Zwirner, J.; Burges, A.; Nieuwland, R.; Toth, B. Circulating microparticles in patients with benign and malignant ovarian tumors. Anticancer Res. 2012, 32 (5), 2009-2014.

Rank A, Liebhardt S, Zwirner J, Burges A, Nieuwland R, Toth B. Circulating microparticles in patients with benign and malignant ovarian tumors. Anticancer Res. 2012;32(5):2009-2014.

A. Rank, S. Liebhardt, J. Zwirner, A. Burges, R. Nieuwland, and B. Toth, “Circulating microparticles in patients with benign and malignant ovarian tumors,” Anticancer Res., vol. 32, no. 5, pp. 2009-2014, May. 2012.

Rank A, Liebhardt S, Zwirner J, Burges A, Nieuwland R, Toth B. Circulating microparticles in patients with benign and malignant ovarian tumors. Anticancer Res. 2012 May;32(5):2009-2014.

Rank, A.; Nieuwland, R.; Nikolajek, K.; Rösner, S.; Wallwiener, L.; Hiller, E.; Toth, B. Hormone replacement therapy leads to increased plasma levels of platelet derived microparticles in postmenopausal women. Arch. Gynecol. Obstet. 2012, 285 (4), 1035-1041.

Rank A, Nieuwland R, Nikolajek K, et al. Hormone replacement therapy leads to increased plasma levels of platelet derived microparticles in postmenopausal women. Arch Gynecol Obstet. 2012;285(4):1035-1041.

A. Rank et al., “Hormone replacement therapy leads to increased plasma levels of platelet derived microparticles in postmenopausal women,” Arch. Gynecol. Obstet., vol. 285, no. 4, pp. 1035-1041, Apr. 2012.

Rank A, Nieuwland R, Nikolajek K, Rösner S, Wallwiener L, Hiller E, et al. Hormone replacement therapy leads to increased plasma levels of platelet derived microparticles in postmenopausal women. Arch Gynecol Obstet. 2012 Apr;285(4):1035-1041.

Lemkes, B.; Bähler, L.; Kamphuisen, P.; Stroobants, A.; Van Den Dool, E.; Hoekstra, J.; Nieuwland, R.; Gerdes, V.; Holleman, F. The influence of aspirin dose and glycemic control on platelet inhibition in patients with type 2 diabetes mellitus. J. Thromb. Haemost. 2012, 10 (4), 639-646.

Lemkes B, Bähler L, Kamphuisen P, et al. The influence of aspirin dose and glycemic control on platelet inhibition in patients with type 2 diabetes mellitus. J Thromb Haemost. 2012;10(4):639-646.

B. Lemkes et al., “The influence of aspirin dose and glycemic control on platelet inhibition in patients with type 2 diabetes mellitus,” J. Thromb. Haemost., vol. 10, no. 4, pp. 639-646, Apr. 2012.

Lemkes B, Bähler L, Kamphuisen P, Stroobants A, Van Den Dool E, Hoekstra J, et al. The influence of aspirin dose and glycemic control on platelet inhibition in patients with type 2 diabetes mellitus. J Thromb Haemost. 2012 Apr;10(4):639-646.

Lok, C. A.; Snijder, K. S.; Nieuwland, R.; van der Post, J. A.; de Vos, P.; Faas, M. M. Microparticles of pregnant women and preeclamptic patients activate endothelial cells in the presence of monocytes. Am. J. Reprod. Immunol. 2012, 67 (3), 206-215.

Lok CA, Snijder KS, Nieuwland R, van der Post JA, de Vos P, Faas MM. Microparticles of pregnant women and preeclamptic patients activate endothelial cells in the presence of monocytes. Am J Reprod Immunol. 2012;67(3):206-215.

C. A. Lok, K. S. Snijder, R. Nieuwland, J. A. van der Post, P. de Vos, and M. M. Faas, “Microparticles of pregnant women and preeclamptic patients activate endothelial cells in the presence of monocytes,” Am. J. Reprod. Immunol., vol. 67, no. 3, pp. 206-215, Mar. 2012.

Lok CA, Snijder KS, Nieuwland R, van der Post JA, de Vos P, Faas MM. Microparticles of pregnant women and preeclamptic patients activate endothelial cells in the presence of monocytes. Am J Reprod Immunol. 2012 Mar;67(3):206-215.

van der Pol, E.; Böing, A. N.; Harrison, P.; Sturk, A.; Nieuwland, R. Classification, functions, and clinical relevance of extracellular vesicles. Pharmacol. Rev. 2012, 64 (3), 676-705.

van der Pol E, Böing AN, Harrison P, Sturk A, Nieuwland R. Classification, functions, and clinical relevance of extracellular vesicles. Pharmacol Rev. 2012;64(3):676-705.

E. van der Pol, A. N. Böing, P. Harrison, A. Sturk, and R. Nieuwland, “Classification, functions, and clinical relevance of extracellular vesicles,” Pharmacol. Rev., vol. 64, no. 3, pp. 676-705, Jul. 2012.

van der Pol E, Böing AN, Harrison P, Sturk A, Nieuwland R. Classification, functions, and clinical relevance of extracellular vesicles. Pharmacol Rev. 2012 Jul;64(3):676-05.

van den Akker, J.; van Weert, A.; Afink, G.; Bakker, E. N. T. P.; van der Pol, E.; Böing, A. N.; Nieuwland, R.; van Bavel, E. Transglutaminase 2 is secreted from smooth muscle cells by transamidation-dependent microparticle formation. Amino Acids 2012, 42 (2), 961-973.

van den Akker J, van Weert A, Afink G, et al. Transglutaminase 2 is secreted from smooth muscle cells by transamidation-dependent microparticle formation. Amino Acids. 2012;42(2):961-973.

J. van den Akker et al., “Transglutaminase 2 is secreted from smooth muscle cells by transamidation-dependent microparticle formation,” Amino Acids, vol. 42, no. 2, pp. 961-973, Jun. 2012.

van den Akker J, van Weert A, Afink G, Bakker ENTP, van der Pol E, Böing AN, et al. Transglutaminase 2 is secreted from smooth muscle cells by transamidation-dependent microparticle formation. Amino Acids. 2012 Jun;42(2):961-73.

Coumans, F. A. W.; van der Pol, E.; Terstappen, L. W. M. M. Flat-top illumination profile in an epi-fluorescence microscope by dual micro lens arrays. Cytom. Part A 2012, 81 (4), 324-331.

Coumans FAW, van der Pol E, Terstappen LWMM. Flat-top illumination profile in an epi-fluorescence microscope by dual micro lens arrays. Cytom Part A. 2012;81(4):324-331.

F. A. W. Coumans, E. van der Pol, and L. W. M. M. Terstappen, “Flat-top illumination profile in an epi-fluorescence microscope by dual micro lens arrays,” Cytom. Part A, vol. 81, no. 4, pp. 324-331, Mar. 2012.

Coumans FAW, van der Pol E, Terstappen LWMM. Flat-top illumination profile in an epi-fluorescence microscope by dual micro lens arrays. Cytom Part A. 2012 Mar;81(4):324-31.

van der pol, E.; van Gemert, M. J. C.; Sturk, A.; Nieuwland, R.; van Leeuwen, T. G. Single vs. swarm detection of microparticles and exosomes by flow cytometry. J. Thromb. Haemost. 2012, 10 (5), 919-930.

van der pol E, van Gemert MJC, Sturk A, Nieuwland R, van Leeuwen TG. Single vs. swarm detection of microparticles and exosomes by flow cytometry. J Thromb Haemost. 2012;10(5):919-930.

E. van der pol, M. J. C. van Gemert, A. Sturk, R. Nieuwland, and T. G. van Leeuwen, “Single vs. swarm detection of microparticles and exosomes by flow cytometry,” J. Thromb. Haemost., vol. 10, no. 5, pp. 919-930, Feb. 2012.

van der pol E, van Gemert MJC, Sturk A, Nieuwland R, van Leeuwen TG. Single vs. swarm detection of microparticles and exosomes by flow cytometry. J Thromb Haemost. 2012 Feb;10(5):919-30.

Vlaar, A. P. J.; Kulik, W.; Nieuwland, R.; Peters, C. P.; Tool, A. T. J.; van Bruggen, R.; Juffermans, N. P.; de Korte, D. Accumulation of bioactive lipids during storage of blood products is not cell but plasma derived and temperature dependent. Transfusion 2011, 51 (11), 2358-2366.

Vlaar APJ, Kulik W, Nieuwland R, et al. Accumulation of bioactive lipids during storage of blood products is not cell but plasma derived and temperature dependent. Transfusion. 2011;51(11):2358-2366.

A. P. J. Vlaar et al., “Accumulation of bioactive lipids during storage of blood products is not cell but plasma derived and temperature dependent,” Transfusion, vol. 51, no. 11, pp. 2358-2366, Nov. 2011.

Vlaar APJ, Kulik W, Nieuwland R, Peters CP, Tool ATJ, van Bruggen R, et al. Accumulation of bioactive lipids during storage of blood products is not cell but plasma derived and temperature dependent. Transfusion. 2011 Nov;51(11):2358-2366.

Rank, A.; Nieuwland, R.; Toth, B.; Pihusch, V.; Delker, R.; Hiller, E.; Kolb, H.; Pihusch, R. Microparticles for diagnosis of graf-versus-host disease after allogeneic stem transplantation. Transplantation 2011, 92 (2), 244-250.

Rank A, Nieuwland R, Toth B, et al. Microparticles for diagnosis of graf-versus-host disease after allogeneic stem transplantation. Transplantation. 2011;92(2):244-250.

A. Rank et al., “Microparticles for diagnosis of graf-versus-host disease after allogeneic stem transplantation,” Transplantation, vol. 92, no. 2, pp. 244-250, Jul. 2011.

Rank A, Nieuwland R, Toth B, Pihusch V, Delker R, Hiller E, et al. Microparticles for diagnosis of graf-versus-host disease after allogeneic stem transplantation. Transplantation. 2011 Jul;92(2):244-250.

Rank, A.; Nieuwland, R.; Delker, R.; Pihusch, V.; Wilkowski, R.; Toth, B.; Kolb, H.; Pihusch, R. Surveillance of megakaryocytic function by measurement of CD61-exposing microparticles in allogeneic hematopoietic stem cell recipients. Clin. Transplant. 2011, 25 (3), E233-E242.

Rank A, Nieuwland R, Delker R, et al. Surveillance of megakaryocytic function by measurement of CD61-exposing microparticles in allogeneic hematopoietic stem cell recipients. Clin Transplant. 2011;25(3):E233-E242.

A. Rank et al., “Surveillance of megakaryocytic function by measurement of CD61-exposing microparticles in allogeneic hematopoietic stem cell recipients,” Clin. Transplant., vol. 25, no. 3, pp. E233-E242, May. 2011.

Rank A, Nieuwland R, Delker R, Pihusch V, Wilkowski R, Toth B, et al. Surveillance of megakaryocytic function by measurement of CD61-exposing microparticles in allogeneic hematopoietic stem cell recipients. Clin Transplant. 2011 May;25(3):E233-E242.

Juffermans, N. P.; Prins, D. J.; Vlaar, A. P. J.; Nieuwland, R.; Binnekade, J. M. Transfusion-related risk of secondary bacterial infections in sepsis patients: a retrospective cohort study. Int. Congr. Ser. 2011, 35 (4), 355-359.

Juffermans NP, Prins DJ, Vlaar APJ, Nieuwland R, Binnekade JM. Transfusion-related risk of secondary bacterial infections in sepsis patients: a retrospective cohort study. Int Congr Ser. 2011;35(4):355-359.

N. P. Juffermans, D. J. Prins, A. P. J. Vlaar, R. Nieuwland, and J. M. Binnekade, “Transfusion-related risk of secondary bacterial infections in sepsis patients: a retrospective cohort study,” Int. Congr. Ser., vol. 35, no. 4, pp. 355-359, Apr. 2011.

Juffermans NP, Prins DJ, Vlaar APJ, Nieuwland R, Binnekade JM. Transfusion-related risk of secondary bacterial infections in sepsis patients: a retrospective cohort study. Int Congr Ser. 2011 Apr;35(4):355-359.

Ayers, L.; Kohler, M.; Harrison, P.; Sargent, I.; Dragovic, R.; Schaap, M.; Nieuwland, R.; Brooks, S. A.; Ferry, B. Measurement of circulating cell-derived microparticles by flow cytometry: Sources of variability within the assay. Thromb. Res. 2011, 127 (4), 370-377.

Ayers L, Kohler M, Harrison P, et al. Measurement of circulating cell-derived microparticles by flow cytometry: Sources of variability within the assay. Thromb Res. 2011;127(4):370-377.

L. Ayers et al., “Measurement of circulating cell-derived microparticles by flow cytometry: Sources of variability within the assay,” Thromb. Res., vol. 127, no. 4, pp. 370-377, Apr. 2011.

Ayers L, Kohler M, Harrison P, Sargent I, Dragovic R, Schaap M, et al. Measurement of circulating cell-derived microparticles by flow cytometry: Sources of variability within the assay. Thromb Res. 2011 Apr;127(4):370-377.

van der Post, J. A. M.; Lok, C. A. R.; Boer, K.; Sturk, A.; Sargent, I. L.; Nieuwland, R. The functions of microparticles in pre-eclampsia. Semin. Thromb. Hemost. 2011, 37 (02), 146-152.

van der Post JAM, Lok CAR, Boer K, Sturk A, Sargent IL, Nieuwland R. The functions of microparticles in pre-eclampsia. Semin Thromb Hemost. 2011;37(02):146-152.

J. A. M. van der Post, C. A. R. Lok, K. Boer, A. Sturk, I. L. Sargent, and R. Nieuwland, “The functions of microparticles in pre-eclampsia,” Semin. Thromb. Hemost., vol. 37, no. 02, pp. 146-152, Mar. 2011.

van der Post JAM, Lok CAR, Boer K, Sturk A, Sargent IL, Nieuwland R. The functions of microparticles in pre-eclampsia. Semin Thromb Hemost. 2011 Mar;37(02):146-152.

Rank, A.; Nieuwland, R.; Liebhardt, S.; Iberer, M.; Grützner, S.; Toth, B.; Pihusch, R. Apheresis platelet concentrates contain platelet-derived and endothelial cell-derived microparticles. Vox Sang. 2011, 100 (2), 179-186.

Rank A, Nieuwland R, Liebhardt S, et al. Apheresis platelet concentrates contain platelet-derived and endothelial cell-derived microparticles. Vox Sang. 2011;100(2):179-186.

A. Rank et al., “Apheresis platelet concentrates contain platelet-derived and endothelial cell-derived microparticles,” Vox Sang., vol. 100, no. 2, pp. 179-186, Feb. 2011.

Rank A, Nieuwland R, Liebhardt S, Iberer M, Grützner S, Toth B, et al. Apheresis platelet concentrates contain platelet-derived and endothelial cell-derived microparticles. Vox Sang. 2011 Feb;100(2):179-186.

Tushuizen, M. E.; Diamant, M.; Sturk, A.; Nieuwland, R. Cell-derived microparticles in the pathogenesis of cardiovascular disease: friend or foe?. Arterioscl. Throm. Vas. 2011, 31 (1), 4-9.

Tushuizen ME, Diamant M, Sturk A, Nieuwland R. Cell-derived microparticles in the pathogenesis of cardiovascular disease: friend or foe?. Arterioscl Throm Vas. 2011;31(1):4-9.

M. E. Tushuizen, M. Diamant, A. Sturk, and R. Nieuwland, “Cell-derived microparticles in the pathogenesis of cardiovascular disease: friend or foe?,” Arterioscl. Throm. Vas., vol. 31, no. 1, pp. 4-9, Jan. 2011.

Tushuizen ME, Diamant M, Sturk A, Nieuwland R. Cell-derived microparticles in the pathogenesis of cardiovascular disease: friend or foe?. Arterioscl Throm Vas. 2011 Jan;31(1):4-9.

Rank, A.; Nieuwland, R.; Crispin, A.; Grützner, S.; Iberer, M.; Toth, B.; Pihusch, R. Clearance of platelet microparticles in vivo. Platelets 2011, 22 (2), 111-116.

Rank A, Nieuwland R, Crispin A, et al. Clearance of platelet microparticles in vivo. Platelets. 2011;22(2):111-116.

A. Rank et al., “Clearance of platelet microparticles in vivo,” Platelets, vol. 22, no. 2, pp. 111-116, Jan. 2011.

Rank A, Nieuwland R, Crispin A, Grützner S, Iberer M, Toth B, et al. Clearance of platelet microparticles in vivo. Platelets. 2011 Jan;22(2):111-116.

Lok, C. A.; van der Post, J. A.; Sturk, A.; Sargent, I. L.; Nieuwland, R. The functions of microparticles in preeclampsia. Pregnancy Hypertens. 2011, 1 (1), 59-65.

Lok CA, van der Post JA, Sturk A, Sargent IL, Nieuwland R. The functions of microparticles in preeclampsia. Pregnancy Hypertens. 2011;1(1):59-65.

C. A. Lok, J. A. van der Post, A. Sturk, I. L. Sargent, and R. Nieuwland, “The functions of microparticles in preeclampsia,” Pregnancy Hypertens., vol. 1, no. 1, pp. 59-65, Jan. 2011.

Lok CA, van der Post JA, Sturk A, Sargent IL, Nieuwland R. The functions of microparticles in preeclampsia. Pregnancy Hypertens. 2011 Jan;1(1):59-65.

Biró, É.; van den Goor, J. M.; de Mol, B. d. M.; Schaap, M. C.; Ko, L.; Sturk, A.; Hack, C.; Nieuwland, R. Complement activation on the surface of cell-derived microparticles during cardiac surgery with cardiopulmonary bypass - is retransfusion of pericardial blood harmful?. Perfusion 2011, 26 (1), 21-29.

Biró É, van den Goor JM, de Mol BdM, et al. Complement activation on the surface of cell-derived microparticles during cardiac surgery with cardiopulmonary bypass - is retransfusion of pericardial blood harmful?. Perfusion. 2011;26(1):21-29.

É. Biró et al., “Complement activation on the surface of cell-derived microparticles during cardiac surgery with cardiopulmonary bypass - is retransfusion of pericardial blood harmful?,” Perfusion, vol. 26, no. 1, pp. 21-29, Jan. 2011.

Biró É, van den Goor JM, de Mol BdM, Schaap MC, Ko L, Sturk A, et al. Complement activation on the surface of cell-derived microparticles during cardiac surgery with cardiopulmonary bypass - is retransfusion of pericardial blood harmful?. Perfusion. 2011 Jan;26(1):21-29.

Berckmans, R. J.; Sturk, A.; van Tienen, L. M.; Schaap, M. C.; Nieuwland, R. Cell-derived vesicles exposing coagulant tissue factor in saliva. Blood 2011, 117 (11), 3172-3180.

Berckmans RJ, Sturk A, van Tienen LM, Schaap MC, Nieuwland R. Cell-derived vesicles exposing coagulant tissue factor in saliva. Blood. 2011;117(11):3172-3180.

R. J. Berckmans, A. Sturk, L. M. van Tienen, M. C. Schaap, and R. Nieuwland, “Cell-derived vesicles exposing coagulant tissue factor in saliva,” Blood, vol. 117, no. 11, pp. 3172-3180, Jan. 2011.

Berckmans RJ, Sturk A, van Tienen LM, Schaap MC, Nieuwland R. Cell-derived vesicles exposing coagulant tissue factor in saliva. Blood. 2011 Jan;117(11):3172-3180.

Nieuwland, R.; van der Post, J. A. M.; Lok, C. A. R.; Kenter, G. G.; Sturk, A. Microparticles and Exosomes in Gynecologic Neoplasias. Semin. Thromb. Hemost. 2010, 36 (8), 925-929.

Nieuwland R, van der Post JAM, Lok CAR, Kenter GG, Sturk A. Microparticles and Exosomes in Gynecologic Neoplasias. Semin Thromb Hemost. 2010;36(8):925-929.

R. Nieuwland, J. A. M. van der Post, C. A. R. Lok, G. G. Kenter, and A. Sturk, “Microparticles and Exosomes in Gynecologic Neoplasias,” Semin. Thromb. Hemost., vol. 36, no. 8, pp. 925-929, Nov. 2010.

Nieuwland R, van der Post JAM, Lok CAR, Kenter GG, Sturk A. Microparticles and Exosomes in Gynecologic Neoplasias. Semin Thromb Hemost. 2010 Nov;36(8):925-929.

Rank, A.; Nieuwland, R.; Delker, R.; Köhler, A.; Toth, B.; Pihusch, V.; Wilkowski, R.; Pihusch, R. Cellular origin of platelet-derived microparticles in vivo. Thromb. Res. 2010, 126 (4), e255-e259.

Rank A, Nieuwland R, Delker R, et al. Cellular origin of platelet-derived microparticles in vivo. Thromb Res. 2010;126(4):e255-e259.

A. Rank et al., “Cellular origin of platelet-derived microparticles in vivo,” Thromb. Res., vol. 126, no. 4, pp. e255-e259, Oct. 2010.

Rank A, Nieuwland R, Delker R, Köhler A, Toth B, Pihusch V, et al. Cellular origin of platelet-derived microparticles in vivo. Thromb Res. 2010 Oct;126(4):e255-e259.

Vlaar, A. P. J.; Hofstra, J. J.; Kulik, W.; van Lenthe, H.; Nieuwland, R.; Schultz, M. J.; Levi, M. M.; Roelofs, J. J. T. H.; Tool, A. T. J.; de Korte, D.; et al. Supernatant of stored platelets causes lung inflammation and coagulopathy in a novel in vivo transfusion model. Blood 2010, 116 (8), 1360-1368.

Vlaar APJ, Hofstra JJ, Kulik W, et al. Supernatant of stored platelets causes lung inflammation and coagulopathy in a novel in vivo transfusion model. Blood. 2010;116(8):1360-1368.

A. P. J. Vlaar et al., “Supernatant of stored platelets causes lung inflammation and coagulopathy in a novel in vivo transfusion model,” Blood, vol. 116, no. 8, pp. 1360-1368, Aug. 2010.

Vlaar APJ, Hofstra JJ, Kulik W, van Lenthe H, Nieuwland R, Schultz MJ, et al. Supernatant of stored platelets causes lung inflammation and coagulopathy in a novel in vivo transfusion model. Blood. 2010 Aug;116(8):1360-1368.

Vlaar, A. P. J.; Hofstra, J. J.; Levi, M.; Kulik, W.; Nieuwland, R.; Tool, A. T. J.; Schultz, M. J.; de Korte, D.; Juffermans, N. P. Supernatant of aged erythrocytes causes lung inflammation and coagulopathy in a “two-hit” in vivo syngeneic transfusion model. Anesthesiology 2010, 113 (1), 92-103.

Vlaar APJ, Hofstra JJ, Levi M, et al. Supernatant of aged erythrocytes causes lung inflammation and coagulopathy in a “two-hit” in vivo syngeneic transfusion model. Anesthesiology. 2010;113(1):92-103.

A. P. J. Vlaar et al., “Supernatant of aged erythrocytes causes lung inflammation and coagulopathy in a “two-hit” in vivo syngeneic transfusion model,” Anesthesiology, vol. 113, no. 1, pp. 92-103, Jul. 2010.

Vlaar APJ, Hofstra JJ, Levi M, Kulik W, Nieuwland R, Tool ATJ, et al. Supernatant of aged erythrocytes causes lung inflammation and coagulopathy in a “two-hit” in vivo syngeneic transfusion model. Anesthesiology. 2010 Jul;113(1):92-103.

Van Eijk, I. C.; Tushuizen, M. E.; Sturk, A.; Dijkmans, B. A. C.; Boers, M.; Voskuyl, A. E.; Diamant, M.; Wolbink, G. J.; Nieuwland, R.; Nurmohamed, M. T. Circulating microparticles remain associated with complement activation despite intensive anti-inflammatory therapy in early rheumatoid arthritis. Ann. Rheum. Dis. 2010, 69 (7), 1378-1382.

Van Eijk IC, Tushuizen ME, Sturk A, et al. Circulating microparticles remain associated with complement activation despite intensive anti-inflammatory therapy in early rheumatoid arthritis. Ann Rheum Dis. 2010;69(7):1378-1382.

I. C. Van Eijk et al., “Circulating microparticles remain associated with complement activation despite intensive anti-inflammatory therapy in early rheumatoid arthritis,” Ann. Rheum. Dis., vol. 69, no. 7, pp. 1378-1382, Jul. 2010.

Van Eijk IC, Tushuizen ME, Sturk A, Dijkmans BAC, Boers M, Voskuyl AE, et al. Circulating microparticles remain associated with complement activation despite intensive anti-inflammatory therapy in early rheumatoid arthritis. Ann Rheum Dis. 2010 Jul;69(7):1378-1382.